Arexvy vs Gardasil 9
A side-by-side look at two vaccine medications advertised on TV. Informational only — not medical advice.
| US Arexvy | US Gardasil 9 | |
|---|---|---|
| Generic name | respiratory syncytial virus vaccine | human papillomavirus 9-valent vaccine |
| Drug class | Recombinant Adjuvanted Vaccine | Vaccine |
| Treats | RSV prevention in older adults | HPV-related cancer prevention |
| Category | Vaccine | Vaccine |
| Manufacturer | GSK | Merck |
| Year approved | 2023 | 2014 |
| FDA warning | No boxed warning | No boxed warning |
| Est. TV ad spend | $110M | — |
| Common side effects | Injection site pain, Fatigue, Muscle pain, Headache | Injection-site pain, Swelling, Headache, Fever |
Gardasil 9
Frequently asked questions
Is Arexvy or Gardasil 9 better?
Neither is universally "better." Arexvy (respiratory syncytial virus vaccine) and Gardasil 9 (human papillomavirus 9-valent vaccine) are both used for vaccine, but the right choice depends on your medical history, insurance and your doctor's guidance. This comparison is informational only.
What's the difference between Arexvy and Gardasil 9?
Arexvy is a Recombinant Adjuvanted Vaccine made by GSK, while Gardasil 9 is a Vaccine made by Merck. See the table above for a side-by-side breakdown.
Which one spends more on TV ads?
Arexvy has the larger estimated TV advertising budget of the two.